4.8 Article

In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pediatrics

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium

Imke Anise Maartje Ditters et al.

Summary: This study assessed the effect of enzyme replacement therapy (ERT) with alglucosidase alfa on survival and walking ability in patients with classic infantile Pompe disease. The results showed that a high ERT dosage of 40 mg/kg per week significantly improved survival compared to the standard recommended dosage of 20 mg/kg every other week. These findings suggest a need for reconsideration of the currently registered dosage.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Article Genetics & Heredity

Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction

Cindy Li et al.

Summary: Early treatment with ERT + ITI in CRIM-negative IPD patients can significantly improve left ventricular mass index, motor and pulmonary outcomes, as well as biomarkers.

GENETICS IN MEDICINE (2021)

Article Genetics & Heredity

The First Year Experience of Newborn Screening for Pompe Disease in California

Hao Tang et al.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2020)

Review Biotechnology & Applied Microbiology

Emptying the stores: lysosomal diseases and therapeutic strategies

Frances M. Platt

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Endocrinology & Metabolism

Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction

Priya S. Kishnani et al.

MOLECULAR GENETICS AND METABOLISM (2016)

Article Genetics & Heredity

A Large-Scale Nationwide Newborn Screening Program for Pompe Disease in Taiwan: Towards Effective Diagnosis and Treatment

Chia-Feng Yang et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)

Article Genetics & Heredity

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy

Sean N. Prater et al.

ORPHANET JOURNAL OF RARE DISEASES (2013)

Article Genetics & Heredity

Assessing disease severity in Pompe disease: The roles of a urinary glucose tetrasaccharide biomarker and imaging techniques

Sarah P. Young et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2012)

Article Endocrinology & Metabolism

Algorithm for Pompe disease newborn screening: Results from the Taiwan screening program

Shu-Chuan Chiang et al.

MOLECULAR GENETICS AND METABOLISM (2012)

Article Endocrinology & Metabolism

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

Priya S. Kishnani et al.

MOLECULAR GENETICS AND METABOLISM (2010)

Article Endocrinology & Metabolism

Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapy

Mohamed A. Hamdan et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2010)

Article Genetics & Heredity

Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease

Roddy McDowell et al.

GENETICS IN MEDICINE (2008)

Review Genetics & Heredity

Sibling phenotype concordance in classical infantile Pompe disease

Wendy E. Smith et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)